AVE(SH:688067) Xin Lang Cai Jing·2026-02-27 08:49Core Viewpoint - Awei Technology reported a total operating revenue of 230 million yuan for the fiscal year 2025, representing a year-on-year growth of 13.14%, and a net profit of 28.9443 million yuan, with a year-on-year increase of 26.72% [1] Revenue Growth - The increase in operating revenue by 13.14% is primarily attributed to strong sales of the vaginal secretion analysis instruments and their accompanying reagents, as well as the upcoming launch of the blood analysis production line in 2024, which contributed significantly to revenue growth [1] Profit Growth - The net profit growth rate of 26.72% outpaced the revenue growth due to several factors: 1. Net profit increased in line with revenue growth, while the company's cost control system, implemented in November 2024, enabled precise expense management, resulting in a lower growth rate of period expenses compared to revenue [1] 2. The company has undertaken various cost-reduction and efficiency-enhancement measures across R&D, procurement, and manufacturing, leading to a decrease in the cost of main products [1]